NCT06860516
HLA Demographics Study in Adults With Type 1 Diabetes
Recruiting · Not specified · GentiBio, Inc · registry updated 2026-08-28
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Inclusion
- Male and female participants aged ≥ 18 to ≤ 55 years, with type 1 DM meeting American Diabetes Association criteria at diagnosis:
- Fasting glucose ≥ 126 mg/dL (7.0 mmol/L), or
- hour oral glucose tolerance test plasma glucose ≥ 200 mg/dL (11.0 mmol/L), or
- Hemoglobin A1c ≥ 6.5%, or
- Random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) (with documented classic hyperglycemia symptoms or hyperglycemic crisis).
- Date of T1D diagnosis within 6 months of the study visit.
Exclusion
- Participant is an employee of, or an immediate family member of an employee, of the Sponsor, study site, or of a contractor/vendor who is involved in direct study conduct for this protocol.
- Participant is unwilling or unable to comply with the study visit assessments.